scispace - formally typeset
X

Xiaoyan Wang

Researcher at Shanghai Jiao Tong University

Publications -  50
Citations -  2151

Xiaoyan Wang is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Metabolite & Metabolome. The author has an hindex of 22, co-authored 44 publications receiving 1861 citations. Previous affiliations of Xiaoyan Wang include University of North Carolina at Greensboro.

Papers
More filters
Journal ArticleDOI

Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma

TL;DR: This work shows that metabolomic profiling approach is a promising screening tool for the diagnosis and stratification of HCC patients with alpha fetoprotein values lower than 20 ng/ml with an accuracy of 100% using a panel of metabolite markers.
Journal ArticleDOI

Potential metabolite markers of schizophrenia

TL;DR: A global metabolic profiling study involving 112 schizophrenic patients and 110 healthy subjects, who were divided into a training set and a test set, designed to identify metabolite markers found multiple fatty acids and ketone bodies elevated, suggesting an upregulated fatty acid catabolism in the brains of schizophrenia patients.
Journal ArticleDOI

Anti-influenza agents from plants and traditional Chinese medicine.

TL;DR: Traditional medicine focuses on the use of herbs and traditional Chinese medicine has performed well in clinical practice and shows a potential in the therapy of influenza and its symptoms.
Journal ArticleDOI

Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress.

TL;DR: It is demonstrated that the significantly perturbed metabolites mainly involving amino acids play an indispensable role in regulating neural activity in the brain and potentially provide a unique perspective on molecular mechanisms of chronic stress.
Journal ArticleDOI

Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers.

TL;DR: Rosiglitazone treatment was able to reverse more abnormal levels of metabolites, such as valine, lysine, glucuronolactone, C16:0, C18:1, urate, and octadecanoate, suggesting that it is more efficient to alter the metabolism of T2DM patients than the other two drugs.